Related Experiment Video
Updated: Jun 12, 2025

10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.1K
Glaucoma Rehabilitation Using ElectricAI Transcranial Stimulation (GREAT)-Optimizing Stimulation Protocol for Vision
Xiaolin Mei1, LaiLin Tsang1, Theodore Jacques1
1School of Optometry, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Translational Vision Science & Technology
|September 20, 2024
Summary
Anodal transcranial direct current stimulation (a-tDCS) improved vision in glaucoma patients. While a single session showed promise for enhancing visual function, the clinical significance requires further investigation.
Area of Science:
- Neuroscience
- Ophthalmology
- Medical Engineering
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Current treatments aim to slow disease progression but do not restore lost vision.
- Non-invasive brain stimulation techniques offer potential novel therapeutic avenues.
Purpose of the Study:
- To investigate the effects of three transcranial electrical stimulation (tES) protocols on visual function in glaucoma patients.
- To compare anodal transcranial direct current stimulation (a-tDCS), transcranial alternating current stimulation (tACS), and transcranial random noise stimulation (tRNS) against sham stimulation.
Main Methods:
- A double-masked, placebo-controlled study involving 35 glaucoma patients.
- Four randomized stimulation sessions: a-tDCS, tACS, tRNS, and sham, with at least 48 hours between sessions.
- Assessment of visual function using high-resolution perimetry (HRP) and multifocal visual evoked potential (mfVEP) before and after each 20-minute stimulation session.
Main Results:
- a-tDCS significantly improved HRP detection accuracy in both central and peripheral visual fields compared to sham.
- a-tDCS also significantly increased mfVEP signal-to-noise ratio (SNR) and reduced latency in the central visual field.
- A trend for improved peripheral mfVEP SNR was observed with a-tDCS, but did not reach statistical significance.
Conclusions:
- A single session of a-tDCS demonstrates potential for enhancing visual perceptual and electrophysiological measures in glaucoma patients.
- The observed improvements, while statistically significant, were of a small magnitude and may not yet be clinically meaningful.
- Further research is warranted to assess long-term effects and clinical relevance using validated perimetric measures.

